Alaa Abd-Elsayed | Neuromidulation | Best Researcher Award

Posted on by sciencefather

Dr. Alaa Abd-Elsayed | Neuromidulation | Best Researcher Award

Dr. Alaa Abd-Elsayed 🇺🇸 is an American board-certified anesthesiologist and pain medicine specialist at the University of Wisconsin-Madison 🏥, recognized for his leadership, groundbreaking research 🔬, and compassionate patient care 💉, with a prolific academic career as a professor, director, and global speaker 🎤, blending clinical excellence, innovation, and education 📚 in pain management, with over two decades of medical service and leadership roles across Egypt 🇪🇬 and the U.S. 🇺🇸, while holding numerous prestigious certifications 🏅, published research, and leadership awards 🏆, he stands as a dedicated pioneer in improving chronic pain therapy 🔥 and anesthesiology practice worldwide 🌍.

Profile

Education 🎓

Dr. Alaa’s academic journey began at Assuit University 🇪🇬, earning his MBBCh 🩺 in 2000 & MPH 🎓 in 2006; postgrad, he trained extensively in the U.S. 🇺🇸, completing internships, anesthesiology residency, and a pain medicine fellowship 🏥 at the University of Cincinnati 🎯, and a Clinical Research Fellowship at Cleveland Clinic 🧪; board-certified in anesthesiology & chronic pain medicine 💊, and a Certified Physician Executive (CPE) 🏆, he capped his academic prowess with an Executive MBA 🎓 in 2023, mastering both medicine & healthcare leadership 🧠, and attending diverse leadership programs 💼 from AAPL, UW Health, and Faulkner University, cementing a strong foundation in clinical care and strategic innovation ⚡.

Experience 👨‍🏫

With over 20 years in medicine 🩺, Dr. Alaa has held roles from intern 👨‍⚕️ in Egypt 🇪🇬 to Associate Professor 📖, First Division Chief, and Medical Director at UW-Madison 🇺🇸; he’s led UW Health Pain Services 🔥, pioneering chronic pain medicine management 💊; his journey spanned positions at Assuit University, Cleveland Clinic, and University of Cincinnati 🏥; he’s served as chief fellow, staff anesthesiologist, researcher 🔬, educator 📚, and leader, combining advanced clinical practice 🏆 with administrative excellence 💼, mentoring future physicians while driving cutting-edge research 🚀 and pain medicine innovations 🌟.

Awards & Recognitions 🏅

Dr. Alaa’s distinguished career is crowned with awards 🌟 like the Raj/Racz Excellence Award 🥇, Physician of the Year 🏅, America’s Top Doctors 👏, Fellow of ASA 🧠, and recognition as a World Expert 🌍 in pain by Expertscape; multiple top research, poster 🖼️, and abstract prizes 🧾 from ASIPP, MARC, ASPN, ASA, INS & WSA 🏆 highlight his prolific contributions, while his books 📚 were ranked among the best in anesthesiology and pain medicine 💊; his research has shaped clinical practices 🌡️ and his leadership has been applauded across national and global stages 🎤, underlining his impact as a clinician, educator, and thought leader 💡.

Research Interests 🔬

Dr. Alaa’s research explores pain management innovation 🔥, neuromodulation ⚡, spinal cord stimulation 🧠, dorsal root ganglion therapies 💉, and anesthesiology outcomes 🧾; he’s passionate about translating bench-to-bedside discoveries 🏥, optimizing patient-centered chronic pain therapies 💊, and advancing perioperative safety 🌡️; his peer-reviewed publications 📚, clinical trials 🧪, and systematic reviews ⚗️ have influenced global practices 🌍, securing his place among top 0.05% scholars worldwide 🏆; his scientific vision combines clinical evidence, bioethics, and real-world health solutions for pain relief and anesthetic care 🧠💡.

Publications 

Tran Chau My Thanh | Neuroscience | Young Scientist Award

Posted on by sciencefather

Dr. Tran Chau My Thanh | Neuroscience | Young Scientist Award

Dr. Tran Chau My Thanh, a dedicated researcher at Duy Tan University, Vietnam 🇻🇳, holds a medical degree and Ph.D. from Hue University of Medicine and Pharmacy 🎓. Her work bridges the gap between clinical medicine and molecular biology 🧬. With a strong passion for translational research, she focuses on using bioinformatics and genomic tools for early diagnosis and targeted therapy development for diseases like cancer, diabetes, and cardiovascular disorders 💉. Through CRISPR/Cas9 and RNA networks, she aims to revolutionize patient-specific treatment pathways 🚀. Her extensive lab experience, scholarly publications, and ongoing innovations make her a promising leader in biomedical science 🏅.

Profile

Education 🎓

Dr. Thanh earned her Medical Degree (M.D.) from Hue University of Medicine and Pharmacy 🏥 and went on to complete her Doctorate (Ph.D.) in the same prestigious institution 🎓. Her education was deeply rooted in both clinical and research training, equipping her with a comprehensive understanding of human health and disease 🧠. Throughout her academic journey, she focused on genomics, molecular medicine, and biotechnology 🔬. The rigorous curriculum and hands-on exposure in advanced labs trained her in modern diagnostic tools and therapeutic innovations ⚙️. She also mastered computational biology and molecular interactions, forming a solid foundation for her groundbreaking work in RNA regulation and gene editing technologies such as CRISPR/Cas9 🧪.

Experience 👨‍🏫

Dr. Thanh brings rich experience as a medical doctor and academic at Duy Tan University 🏫. Her research career spans multiple roles in molecular diagnostics, bioinformatics, and therapeutic innovation 🧬. She has led studies on disease biomarkers, participated in international collaborations 🌐, and worked extensively with cell lines, recombinant DNA, and next-gen sequencing data 🔍. Her proficiency in wet lab and dry lab environments empowers her to integrate experimental biology with computational modeling 🧫💻. Alongside mentoring students and publishing SCI-indexed research, she contributes to translational medicine by connecting bench science to bedside applications, helping advance precision medicine for critical illnesses 💡.

Awards & Recognitions 🏅

Dr. Thanh is a nominee for the Young Scientist Award by the International Cognitive Scientist Awards 🧠🏆. Her impactful work on circular RNAs, miRNAs, and disease biomarker networks has garnered international recognition 🌍. She’s been acknowledged in high-impact journals for discoveries related to coronary heart disease and cancer diagnostics 📖. Her scholarly articles are indexed in SCI and Scopus, and she continues to influence the biomedical community through conference presentations, peer reviews, and academic collaborations 🤝. As a rising figure in molecular biology, her research promises transformative outcomes for early disease detection and targeted therapies 🧬✨.

Research Interests 🔬

Dr. Thanh’s research explores circRNA/miRNA/mRNA interactions, protein-protein networks, and gene function analysis 🧬🧠. She is driven by the quest to discover novel biomarkers for early diagnosis of complex diseases such as cancer, stroke, and diabetes 💊. Her focus includes CRISPR/Cas9 gene editing, molecular docking, and simulations for drug discovery and target validation 💻🧪. She also builds interaction networks to map LncRNA/CircRNA/miRNA/gene/protein-drug relationships, contributing to personalized medicine approaches 🎯. Through bioinformatics, she decodes gene expression dynamics and immune infiltrations to enable efficient diagnostics and therapeutics 💡. Her ultimate goal is to bridge computational biology with translational research for global health improvement 🌐💚.

Publications 

1. Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression
by sponging miRNA-338-3p via regulating the expression of ETS1
2. Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as
potential biomarker for coronary heart disease
3. Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of
bioinformatics data

Ata Jahangir Moshayedi | Brain Stimulation | Best Researcher Award

Posted on by sciencefather

Dr. Ata Jahangir Moshayedi | Brain Stimulation | Best Researcher Award

Dr. Ata Jahangir Moshayedi is an Associate Professor at Jiangxi University of Science and Technology 🇨🇳 with a PhD in Electronic Science 🎓 from Savitribai Phule Pune University 🇮🇳. He is a prolific academic 🧠 with over 90 publications 📚, three authored books 📖, two patents 🧾, and nine copyrights 📝. A distinguished member of IEEE ⚡, ACM 💻, Instrument Society of India 🧪, and Speed Society of India 🚀, he contributes to editorial boards 🗞️ and international conferences 🌐. His interdisciplinary expertise bridges robotics 🤖, AI 🤖, VR 🕶️, and embedded systems 🔧, driving innovation in education and technology 🚀.

Profile

Education 🎓

Dr. Moshayedi earned his PhD in Electronic Science from Savitribai Phule Pune University 🇮🇳, specializing in robotics and automation 🤖. His educational path is deeply rooted in multidisciplinary technologies like embedded systems 🔧, machine vision 👁️, and AI 🧠. With academic training grounded in both theory 📘 and application 🛠️, he cultivated expertise across digital systems 💡 and bio-inspired robots 🦾. He integrates engineering principles with computer science 💻 to develop cutting-edge innovations in virtual and intelligent systems 🌍. His educational achievements laid the foundation for his impactful career in academic research and mentoring 📈.

Experience 👨‍🏫

Dr. Moshayedi has served as Associate Professor at Jiangxi University of Science and Technology 🇨🇳 since 2018. He leads modules in Robotics 🤖, Embedded Systems 💻, and Digital Image Processing 📷. He supervises UG and PG research 🧪, formulates grant proposals 💡, and serves as a module leader and tutor across advanced computer engineering courses 🧑‍🎓. His role includes designing learning materials 📘, aligning curriculum with accreditation standards 🎯, and evaluating student performance 🎓. He has extensive teaching experience in C/C++ programming 💾, algorithm analysis 📊, and mobile app programming 📱, ensuring comprehensive academic development.

Awards & Recognitions 🏅

🥇2024: Best Mentor, Jiangxi University 👨‍🏫 | 🏅2022: Book Award (Unity in Embedded System Design and Robotics) 📖 | 🥉2022: 3rd National & 1st Provincial Prize, Handy Pipe Detector, China Computer Design Competition 🛠️ | 🥉2021: 3rd National & 2nd Provincial, PEA Project (Pandemic Exam Assistant) 🧪 | 🏆2021: Innovation Award, Iran National Festival 🌍 | 🥉2021: 3rd National & 2nd Provincial, RDK Cloud Robot, Intelligent Service Robot Challenge ☁️🤖 — All reflecting his excellence in guiding innovation, mentoring students 👨‍🎓, and advancing global tech competitions 🌐.

Research Interests 🔬

Dr. Moshayedi’s research integrates robotics 🤖, AI 🧠, and embedded systems 🔧. His work on bio-inspired robots 🐜, mobile robot olfaction 👃, and sensor modeling 🧪 explores intelligent perception and environmental interaction 🌫️. He develops machine vision-based systems 👁️, virtual reality environments 🕶️, and smart embedded architectures 🖥️. His focus on plume tracking 🌬️ and cloud robotics ☁️ brings autonomous systems closer to real-world application. Merging theory and practice 🔍, his research propels innovation across intelligent systems, cyber-physical interaction 🌐, and real-time automation, making significant strides in modern engineering and applied AI 🤖.

Publications 

Yuanyuan Li | Movement Disorder | Best Researcher Award

Posted on by sciencefather

Dr. Yuanyuan Li | Movement Disorder | Best Researcher Award

🧠 Dr. Yuanyuan Li is a dedicated neurologist and researcher specializing in neurodegenerative diseases, particularly Parkinson’s disease and REM sleep behavior disorder. She obtained her Ph.D. in Neurology from Shanghai Jiao Tong University School of Medicine and has been actively involved in cutting-edge research at Ruijin Hospital’s Department of Neurology. As a project leader, she has explored the role of α-synuclein in dopaminergic neurons, investigating its transport pathways and impact on cell viability. Dr. Li has authored multiple high-impact publications in renowned journals such as Neurology and J Neuroinflammation. Her work has contributed significantly to understanding the early biomarkers of neurodegenerative disorders. She has received prestigious awards, including the National Scholarship for Doctoral Students and the Outstanding Graduate Award from Shanghai Jiao Tong University. With numerous conference presentations and accolades, Dr. Li continues to drive forward advancements in neurodegenerative disease research. ✨📚

Profile

Education 🎓

🎓 Dr. Yuanyuan Li completed her Ph.D. in Neurology at Shanghai Jiao Tong University School of Medicine, where she focused on neurodegenerative diseases, particularly Parkinson’s disease and REM sleep behavior disorder. Her doctoral research emphasized the role of α-synuclein in dopaminergic neurons, uncovering its impact on neurodegeneration. Throughout her academic journey, Dr. Li consistently demonstrated excellence, earning the First-Class Academic Scholarship and the Meritorious Student Award. She was recognized as an Outstanding Graduate and received the prestigious National Scholarship for Doctoral Students. Beyond coursework, she actively engaged in translational research, bridging laboratory findings with clinical applications. Her education has provided a strong foundation in neurobiology, molecular neuroscience, and clinical neurology. With a passion for uncovering early biomarkers of neurodegeneration, Dr. Li’s educational background has shaped her into a leading researcher in the field. 📖🧬

Experience 👨‍🏫

Dr. Yuanyuan Li has extensive research experience at Ruijin Hospital’s Department of Neurology, affiliated with Shanghai Jiao Tong University School of Medicine. As a principal investigator, she led the Shanghai Jiao Tong University Doctoral Innovation Fund project, studying α-synuclein’s transport mechanisms in dopaminergic neurons and its effects on cell viability. Her expertise spans biomarker discovery, neuroinflammation, and disease progression in neurodegenerative disorders. She has collaborated on numerous high-impact studies published in Neurology, J Neuroinflammation, and NPJ Parkinson’s Disease. Dr. Li has also presented her findings at major conferences, including the National Neurology Conference and the Oriental Neurology Conference. Her experience in both basic and clinical research allows her to bridge the gap between laboratory discoveries and patient applications, advancing diagnostic and therapeutic strategies for Parkinson’s disease and related disorders. 🏥🧠

Awards & Recognitions 🏅

Dr. Yuanyuan Li has received numerous prestigious awards for her contributions to neurology and neuroscience research. She was awarded the National Scholarship for Doctoral Students, recognizing her academic excellence and groundbreaking research. She also received the Outstanding Graduate Award and the Meritorious Student Award from Shanghai Jiao Tong University. Her outstanding academic performance earned her the First-Class Academic Scholarship, demonstrating her dedication to advancing neurological research. Dr. Li has been recognized for her contributions at major conferences, winning the “Excellent Paper Presentation” award at the Oriental Neurology Conference. Additionally, she secured First Prize for Poster Presentation at the “Bo Ji Yi Yuan” Academic Forum. Her accolades reflect her commitment to advancing our understanding of neurodegenerative diseases, particularly Parkinson’s disease. These honors highlight her as a rising star in the field of neurology. 🏅📜

Research Interests 🔬

🧪 Dr. Yuanyuan Li’s research focuses on neurodegenerative diseases, with an emphasis on Parkinson’s disease, REM sleep behavior disorder (RBD), and α-synuclein pathology. Her work explores the molecular mechanisms driving these disorders, particularly the role of α-synuclein in dopaminergic neurons, its transport pathways, and its impact on cell viability. She has also investigated immune biomarkers, neuroinflammation, and genetic variants associated with Parkinson’s progression. Dr. Li’s studies have contributed to identifying predictive markers for early-stage neurodegenerative diseases, aiding in early diagnosis and potential therapeutic interventions. Through her publications in top journals like Neurology, J Neuroinflammation, and NPJ Parkinson’s Disease, she has advanced knowledge in the field. Her work integrates clinical and experimental neuroscience, bridging gaps between laboratory findings and real-world applications. Dr. Li’s research continues to shape the understanding of neurodegenerative disorders and their early detection. 🧬🔍

 

4Publications 

  • Gene Polymorphisms of Parkinson’s Disease Risk Locus and Idiopathic REM Sleep Behavior Disorder

    Biomedicines
    2025-03-24 | Journal article
    DOI: 10.3390/biomedicines13040788
    CONTRIBUTORS: Min Zhong; Yang Jiao; Aonan Zhao; Mengyue Niu; Jinjun Ran; Jun Liu; Yuanyuan Li

  • Understanding Causal Relationships Between Imaging-Derived Phenotypes and Parkinson’s Disease: A Mendelian Randomization and Observational Study

    Biomedicines
    2025-03-18 | Journal article
    DOI: 10.3390/biomedicines13030747
    CONTRIBUTORS: Yichi Zhang; Min Zhong; Zhao Yang; Xiaojin Wang; Zhongxun Dong; Liche Zhou; Qianyi Yin; Bingshun Wang; Jun Liu; Yuanyuan Li et al.

  • Understanding Causal Relationships between Imaging-Derived Phenotypes and Parkinson’s Disease: A Mendelian Randomization and Observational Study

    2025-02-05 | Preprint
    DOI: 10.20944/preprints202502.0350.v1
    CONTRIBUTORS: Yichi Zhang; Min Zhong; Zhao Yang; Xiaojin Wang; Zhongxun Dong; Liche Zhou; Qianyi Yin; Bingshun Wang; Jun Liu; Yuanyuan Li et al.

  • Network disruption based on multi-modal EEG-MRI in α-synucleinopathies

    Frontiers in Neurology
    2024 | Journal article
    DOI: 10.3389/FNEUR.2024.1442851
    WOSUID: WOS:001304283700001
    CONTRIBUTORS: Wang, Chunyi; Hu, Jiajia; Li, Puyu; Zhang, Ming; Zhou, Liche; Luo, Ningdi; Zhu, Xue; Yin, Qianyi; Zhong, Min; Zhou, Xinyi et al.

Marcelo Luis Berthier | Neuroscience| Best Researcher Award

Posted on by sciencefather

Prof. Marcelo Luis Berthier | Neuroscience| Best Researcher Award

 

Unversidad de Málaga, Spain

Profile

Education

Marcelo Luis Berthier obtained his degree in Medicine (1972-1976) and completed residency training in Neurosurgery (1977-1980), later specializing in Neurology (1980). He served as a staff neurologist at the Institute of Neurological Research, FLENI, Buenos Aires, Argentina (1980-1989), before becoming a research fellow in the Department of Neurology at Clinic Hospital of Barcelona, Spain (1989-1990). From 1991 to 2000, he was a staff neurologist and physician in charge of the Behavioural Neurology Unit at the Clinic University Hospital of Malaga. He earned a PhD in Neuroscience (cum laude) from the University of Malaga and coordinated the Group of Behavioural Neurology and Dementia of the Spanish Neurological Society (2004-2006). In 2004, he founded and directed the Unit of Cognitive Neurology and Aphasia at the Centro de Investigaciones Médico-Sanitarias, University of Malaga, leading it until 2023. Additionally, he served as the director of the Consolidated Research Group on Cognitive Neuroscience: Aphasia and Related Disorders (UNCA, C-12) at the Instituto de Investigación Biomédica de Málaga (IBIMA – Plataforma BIONAND).

Work experience

Dr. Marcelo L. Berthier Torres has led and contributed to several groundbreaking research projects in cognitive neurology and aphasia. As a co-investigator, he participated in the Telerehabilitation in Aphasia project (2021-2023), which evaluated the effectiveness of telerehabilitation compared to face-to-face therapy and identified predictive biomarkers of response, funded by the Junta de Andalucía. He also served as the principal investigator for a study on the efficacy of combined treatment with donepezil, intensive rehabilitation, and transcranial direct current stimulation in chronic post-stroke aphasia (2016-2019), funded by the Instituto de Salud Carlos III. Additionally, he has contributed to the Proyectos de Generación de Conocimiento “Frontera”, an initiative under the FEDER Andalucía 2014-2020 program, which investigates brain biomarkers for individualized treatment approaches in chronic post-stroke aphasia

Areas of Research

Dr. Marcelo L. Berthier Torres has made significant contributions to the treatment of post-stroke aphasia and speech-language disorders. He conducted the first open-label and randomized, placebo-controlled, double-blind trials investigating the use of cognitive-enhancing drugs (donepezil and memantine) alone and in combination with standard aphasia therapy or intensive language-action therapy (ILAT) in chronic post-stroke aphasia. His pioneering studies stimulated international research on aphasia pharmacotherapy, leading to clinical translation. Today, donepezil and memantine, alone or combined with therapy, are widely used off-label for post-stroke aphasia and language disturbances associated with neurodegenerative disorders like Alzheimer’s disease and primary progressive aphasia.

Publication

  • Revisiting the boundaries of different altered accents profiles

    Cortex
    2025-03 | Journal article
    DOI: 10.1016/j.cortex.2025.01.001
    CONTRIBUTORS: Marcelo L. Berthier; Ignacio Moreno-Torres; Jo Verhoeven; Guadalupe Dávila

  • Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System

    CNS Drugs
    2023-07 | Journal article
    DOI: 10.1007/s40263-023-01017-4
    CONTRIBUTORS: Guadalupe Dávila; María José Torres-Prioris; Diana López-Barroso; Marcelo L. Berthier

  • Pharmacotherapy for post-stroke aphasia: what are the options?

    Expert Opinion on Pharmacotherapy
    2023-07-24 | Journal article
    DOI: 10.1080/14656566.2023.2221382
    CONTRIBUTORS: Marcelo L. Berthier; Guadalupe Dávila

  • Brain structural and functional correlates of the heterogenous progression of mixed transcortical aphasia

    Brain Structure and Function
    2023-05-31 | Journal article
    DOI: 10.1007/s00429-023-02655-6
    CONTRIBUTORS: Diana López-Barroso; José Paredes-Pacheco; María José Torres-Prioris; Guadalupe Dávila; Marcelo L. Berthier

  • Controlling the past, owning the present, and future: cholinergic modulation decreases semantic perseverations in a person with post-stroke aphasia

    Aphasiology
    2022-11-02 | Journal article
    DOI: 10.1080/02687038.2021.1957082
    CONTRIBUTORS: Marcelo L. Berthier; Daniel Santana-Moreno; Álvaro Beltrán-Corbellini; Juan C. Criado-Álamo; Lisa Edelkraut; Diana López-Barroso; Guadalupe Dávila; María José Torres-Prioris